NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+1.82%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.13B
AUM Growth
+$2.13B
Cap. Flow
+$218M
Cap. Flow %
10.24%
Top 10 Hldgs %
77.62%
Holding
31
New
3
Increased
–
Reduced
2
Closed
–

Top Buys

1
OPWR
OPOWER INC COM STK (DE)
OPWR
$170M
2
TRIV
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$61.4M
3
AGRX
Agile Therapeutics, Inc
AGRX
$191K

Top Sells

1
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$13M
2
GRPN icon
Groupon
GRPN
$60

Sector Composition

1 Healthcare 46.08%
2 Technology 21.26%
3 Communication Services 18.81%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GRPN icon
1
Groupon
GRPN
$1.06B
$360M 16.88% 54,351,573 -9 -0% -$60
TSRO
2
DELISTED
TESARO, Inc.
TSRO
$307M 14.38% 9,854,255 – –
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$201M 9.41% 6,446,089 – –
CVT
4
DELISTED
CVENT, INC.
CVT
$174M 8.18% 5,996,212 – –
OPWR
5
DELISTED
OPOWER INC COM STK (DE)
OPWR
$170M 7.96% +8,997,290 New +$170M
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$2.53B
$116M 5.42% 10,650,000 – –
CLVS
7
DELISTED
Clovis Oncology, Inc.
CLVS
$94.4M 4.43% 2,279,781 – –
RNA
8
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$81.8M 3.84% 6,480,171 – –
FIO
9
DELISTED
FUSION-IO INC COM
FIO
$79.5M 3.73% 7,038,379 – –
CBIO
10
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$72.3M 3.39% 8,575,135 – –
HPTX
11
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$62.2M 2.92% 2,384,221 -500,000 -17% -$13M
TRIV
12
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$61.4M 2.88% +3,945,191 New +$61.4M
ITMN
13
DELISTED
INTERMUNE INC
ITMN
$59.2M 2.78% 1,341,000 – –
MM
14
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$41M 1.93% 8,224,752 – –
VIRX
15
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$36.8M 1.72% 5,636,573 – –
WIFI
16
DELISTED
Boingo Wireless, Inc.
WIFI
$30.5M 1.43% 4,467,960 – –
NKTR icon
17
Nektar Therapeutics
NKTR
$568M
$23.4M 1.1% 1,825,600 – –
TRVN
18
DELISTED
Trevena, Inc.
TRVN
$21.5M 1.01% 3,811,691 – –
GYRE icon
19
Gyre Therapeutics
GYRE
$703M
$20.6M 0.97% 4,566,666 – –
FOLD icon
20
Amicus Therapeutics
FOLD
$2.34B
$18.9M 0.89% 5,653,029 – –
LXRX icon
21
Lexicon Pharmaceuticals
LXRX
$400M
$18.8M 0.88% 11,676,000 – –
DZSI
22
DELISTED
DZS Inc. Common Stock
DZSI
$14.8M 0.7% 4,781,290 – –
ECOM
23
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$14.7M 0.69% 556,692 – –
ALIM
24
DELISTED
Alimera Sciences, Inc.
ALIM
$13.5M 0.63% 2,255,639 – –
OREX
25
DELISTED
Orexigen Therapeutics, Inc.
OREX
$12M 0.56% 1,935,300 – –
1
2